Table 2.
Patient demographic and laboratory characteristics
| Characteristic | Patients (total=63) |
|---|---|
| Age (year), mean±s.d. | 57.11±5.06 |
| BMI (kg m−2), mean±s.d. | 24.87±4.09 |
| ED duration (year), mean±s.d. | 2.10±0.46 |
| DM duration (year), mean±s.d. | 8.46±2.65 |
| HbA1c (%), mean±s.d. | 7.24±1.06 |
| Total testosterone (ng dl−1), mean±s.d. | 464.48±125.36 |
| Patients, n (%) | |
| DM | 63 (100.0) |
| Oral antidiabetic agent use | 57 (90.5) |
| Insulin use | 6 (9.5) |
| Anticoagulant agent use | 17 (27.0) |
| Vascular insufficiency established by penile doppler ultrasonography | 63 (100.0) |
| PDE5Is treatment | 63 (100.0) |
| Smoking history | 20 (31.7) |
| Hypercholesterolemia | 29 (46.0) |
| Hypertension | 38 (63.8) |
| MI history | 9 (14.3) |
s.d.: standard deviation; BMI: body mass index; ED: erectile dysfunction; DM: diabetes mellitus; HbA1c: hemoglobin A1c; PDE5Is: phosphodiesterase 5 inhibitors; MI: myocardial infarction